|

Aminohippurate Sodium Inj 20% Clinical Trials

2 actively recruiting trials across 1 location

Also known as: -Sodium 4-amino hippurate (PAH) inj 20% 2g/10mL -Para-aminohippurate, Aminohippuric acid, Para-aminohippurate, Sodium 4-amino hippurate (PAH) inj 20% 2g/10mL

Pipeline

Phase 2: 1

Top Sponsors

  • University of Colorado, Denver1
  • Petter Bjornstad1

Indications

  • Diabetic Kidney Disease2
  • Diabetes2
  • Adolescent Obesity1
  • Kidney Hypoxia1
  • Pre Diabetes1

Aurora, Colorado2 trials

Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)

Children's Hospital Colorado

Renal Mechanism of SGLT2 Inhibition

University of Colorado Denver

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.